Table 3.
Association of variables with eCrcl on 1 year
| Estimated-creatinine clearance (mL/min) | p Value | |
|---|---|---|
| Kidney vs SPKT | 57.88±15.47 vs 71.38±13.45 | 0.001 |
| DGF (yes vs no) | 56.15±17.55 vs 64.08±15.87 | 0.05 |
| Recipient gender (m vs f) | 59.83±16.02 vs 65±18.07 | 0.2 |
| Donor gender (m vs f) | 63.87±16.71 vs 58.60±16.58 | 0.17 |
| Donor source (D vs L) | 62.36±17.85 vs 59.43±14.05 | 0.47 |
| Steroid-free (yes vs no) | 63.94±17.73 vs 59.39±15.81 | 0.23 |
| Acute rejection (yes vs no) | 61.64±16.59 vs 61.39±16.97 | 0.95 |
| R | p Value | |
| Recipient age | −0.45 | <0.001 |
| Donor age | −0.46 | <0.001 |
| HLA MM | 0.07 | 0.52 |
| Average tacrolimus concentration | −0.02 | 0.9 |
| Average MMF dose | 0.18 | 0.1 |
| ci at 1 year post-transplantation | −0.34 | 0.002 |
| ct at 1 year post-transplantation | −0.35 | 0.002 |
| cv at 1 year post-transplantation | −0.20 | 0.07 |
DGF, delayed graft function; HLA, human leucocyte antigen; MMF, mycophenolate mofetil; MM, mismatch; SPKT, simultaneous pancreas-kidney transplant.